New-onset Adult-onset Still's Disease Following COVID-19 Vaccination: Three Case Reports and a Literature Review
Mayumi Matsuda, Yu Asanuma, Kazuhiro Yokota, Sakon Sakai, Hiroaki Yazawa, Takashi Maruyama, Takuma Tsuzuki Wada, Yasuto Araki, Toshihide Mimura
Abstract
Since December 2020, coronavirus disease 2019 (COVID-19) vaccines have been distributed in most countries to prevent the onset and aggravation of COVID-19. There is little information regarding the long-term safety of the vaccines. We report three cases and a literature review of new-onset adult-onset Still's disease (AOSD) that occurred following COVID-19 vaccination. Our cases include moderate to severe AOSD, and two were complicated with macrophage activation syndrome. Seventeen cases of new-onset or relapse of AOSD following COVID-19 vaccination, including 14 identified in the literature review and our 3 patients, were all treated successfully with glucocorticoid therapy, immunosuppressive drugs, or biologic agents.